First Time Loading...
G

Gentian Diagnostics ASA
OSE:GENT

Watchlist Manager
Gentian Diagnostics ASA
OSE:GENT
Watchlist
Price: 37.6 NOK -0.53%
Updated: May 16, 2024
Section:
 

Relative Value

The Relative Value of one GENT stock under the Base Case scenario is 33.99 NOK. Compared to the current market price of 37.6 NOK, Gentian Diagnostics ASA is Overvalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GENT Relative Value
Base Case
33.99 NOK
Overvaluation 10%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

4.3
P/S
P/S
Price to Sales
4.3
vs History
98
vs Industry
31
Median 3Y
6.7
Median 5Y
12.8
Industry
2.4
Forward
3.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-46.6
Median 5Y
-42.4
Industry
23.9
Forward
-49.2
More Details
37.5
P/OCF
P/OCF
Price to OCF
37.5
vs History
12
vs Industry
10
Median 3Y
-41
Median 5Y
-45.2
Industry
15.6
More Details
91
P/FCFE
P/FCFE
Price to FCFE
91
vs History
7
vs Industry
7
Median 3Y
-25.3
Median 5Y
-32.1
Industry
22.5
More Details
4
P/B
P/B
Price to Book Value
4
vs History
65
vs Industry
22
Median 3Y
4.2
Median 5Y
4.2
Industry
2.3
More Details
3.7
EV/S
EV/S
Enterprise Value to Sales
3.7
vs History
98
vs Industry
32
Median 3Y
5.9
Median 5Y
10.3
Industry
2.5
Forward
2.9
More Details
8.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.9
vs History
95
vs Industry
26
Median 3Y
12.7
Median 5Y
19.8
Industry
5.3
More Details
210.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
210.5
vs History
12
vs Industry
1
Median 3Y
-43.3
Median 5Y
-43.2
Industry
12.9
Forward
245.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-44.2
Median 5Y
-37.3
Industry
17.8
Forward
-44.7
More Details
32.4
EV/OCF
EV/OCF
Enterprise Value to OCF
32.4
vs History
12
vs Industry
13
Median 3Y
-37.3
Median 5Y
-37.3
Industry
15.4
More Details
45.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
45.7
vs History
7
vs Industry
11
Median 3Y
-25.3
Median 5Y
-27.6
Industry
19.6
More Details
5.6
EV/IC
EV/IC
Enterprise Value to IC
5.6
vs History
80
vs Industry
16
Median 3Y
6
Median 5Y
8.8
Industry
2
More Details

Multiples Across Competitors

GENT Competitors Multiples
Gentian Diagnostics ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Gentian Diagnostics ASA
OSE:GENT
579.9m NOK 4.3 -54.5 210.5 -69.8
CH
Alcon AG
SIX:ALC
39.8B CHF 4.7 45.4 20 40.7
JP
Hoya Corp
TSE:7741
6.8T JPY 9 40.5 24.7 30.5
DK
Coloplast A/S
CSE:COLO B
188.3B DKK 7.5 38.7 25.5 29.6
US
Align Technology Inc
NASDAQ:ALGN
21.1B USD 5.4 45.6 25 30.4
US
Cooper Companies Inc
NYSE:COO
19.5B USD 5.3 66.9 24.2 41.2
KR
HLB Inc
KOSDAQ:028300
12.3T KRW 286.4 -65 -105.8 -97.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
58.5B CNY 14.4 33.9 29.9 29.9
UK
ConvaTec Group PLC
LSE:CTEC
5.5B GBP 3.2 53.1 46.9 51
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
5.9B USD 1.5 -61.8 11.7 26.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.5B USD 4 12 10 11.3

See Also

Summary
GENT intrinsic value, competitors valuation, and company profile.
DCF Valuation
GENT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GENT stock valuation using valuation multiples.
Wall Street Estimates
GENT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GENT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.